Thorell Marella 4
4 · Evelo Biosciences, Inc. · Filed May 9, 2023
Insider Transaction Report
Form 4
Thorell Marella
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-07+130,000→ 130,000 total - Exercise/Conversion
Restricted Stock Units
2023-05-07−130,000→ 390,000 total→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. These RSUs have no expiration date.